Chapter 17 Hereditary spastic paraparesis

Handbook of Clinical Neurology

Volumn 82, Issue , 2007, Pages 327-352

  McDermott, Christopher J ^a   Shaw, Pamela J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649357166     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)80020-0     Document Type: Article

References (195)

1. Abdallat A., Davis S.M., Farrage J., and McDonald W.I. Disordered pigmentation, spastic paraparesis and peripheral neuropathy in three siblings: a new neurocutaneous syndrome. J Neurol Neurosurg Psychiatry 43 (1980) 962-966
2. Abel A., Fonknechten N., Hofer A., Durr A., Cruaud C., Voit T., Weissenbach J., Brice A., Klimpe S., Auburger G., and Hazan J. Early onset autosomal dominant spastic paraplegia caused by novel mutations in SPG3A. Neurogenetics 5 (2004) 239-243
3. Allan W., Herndon C.N., and Dudley F.C. Some examples of the inheritance of mental deficiency: apparently sexlinked idiocy and microcephaly. Am J Ment Defic 48 (1944) 325-334
4. Ashley-Koch A., Bonner E.R., Gaskell P.C., West S.G., Tim R., Wolpert C.M., Jones R., Farrell C.D., Nance M., Svenson I.K., Marchuk D.A., Boustany R.M., Vance J.M., Scott W.K., and Pericak-Vance M.A. Fine mapping and genetic heterogeneity in the pure form of autosomal dominant familial spastic paraplegia. Neurogenetics 3 (2001) 91-97
5. Atorino L., Silvestri L., Koppen M., Cassina L., Ballabio A., Marconi R., Langer T., and Casari G. Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J Cell Biol 163 (2003) 777-787
6. Bamforth J.S. Vitiligo-spasticity syndrome: new case. Clin Dysmorphol 12 (2003) 137-139
7. Banfi S., Bassi M.T., Andolfi G., Marchitiello A., Zanotta S., Ballabio A., Casari G., and Franco B. Identification and characterization of AFG3L2, a novel paraplegin-related gene. Genomics 59 (1999) 51-58
8. Bateman A., Jouet M., MacFarlane J., Du J.S., Kenwrick S., and Chothia C. Outline structure of the human L1 cell adhesion molecule and the sites where mutations cause neurological disorders. EMBO J 15 (1996) 6050-6059
9. Behan W.M.H., and Maia M. Strumpell's familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry 37 (1974) 8-20
10. Bialer M.G., Lawrence L., Stevenson R.E., Silverberg G., Williams M.K., Arena J.F., Lubs H.A., and Schwartz C.E. Allan-Herndon-Dudley syndrome: clinical and linkage studies on a second family. Am J Med Genet 43 (1992) 491-497
11. Blumen S.C., Bevan S., Abu-Mouch S., Negus D., Kahana M., Inzelberg R., Mazarib A., Mahamid A., Carasso R.L., Slor H., Withers D., Nisipeanu P., Navon R., and Reid E. A locus for complicated hereditary spastic paraplegia maps to chromosome 1q24-q32. Ann Neurol 54 (2003) 796-803
12. author reply 1471. Bohan T.P., and Azizi P. Allan-Herndon-Dudley syndrome: should the locus for this hereditary spastic paraplegia be designated SPG 22?. Arch Neurol 61 (2004) 1470-1471
13. Boison D., and Stoffel W. Disruption of the compacted myelin sheets of axons of the central nervous system in proteolipid protein-deficient mice. Proc Natl Acad Sci (USA) 91 (1994) 11709-11713
14. Bond C., Si X., Crisp M., Wong P., Paulson G.W., Boesel C.P., Dlouhy S.R., and Hodes M.E. Family with Pelizaeus-Merzbacher disease/X-linked spastic paraplegia and a nonsense mutation in exon 6 of the proteolipid protein gene. Am J Med Genet 71 (1997) 357-360
15. Bonneau D., Rozet J.-M., Bulteau C., Berthier M., Mettey R., Gil R., Munnich A., and Le Merrer M. X-linked spastic paraplegia (SPG2): clinical heterogeneity at a single locus. J Med Genet 30 (1993) 381-384
16. Bonsch D., Schwindt A., Navratil P., Palm D., Neumann C., Klimpe S., Schickel J., Hazan J., Weiller C., Deufel T., and Liepert J. Motor system abnormalities in hereditary spastic paraparesis type 4 (SPG4) depend on the type of mutation in the spastin gene. J Neurol Neurosurg Psychiatry 74 (2003) 1109-1112
17. Bouslam N., Benomar A., Azzedine H., Bouhouche A., Namekawa M., Klebe S., Charon C., Durr A., Ruberg M., Brice A., Yahyaoui M., and Stevanin G. Mapping of a new form of pure autosomal recessive spastic paraplegia (SPG28). Ann Neurol 57 (2005) 567-571
18. Brummendorf T., and Rathjen F.G. Structure/function relationships of axon-associated adhesion receptors of the immunoglobulin superfamily. Curr Opin Neurobiol 6 (1996) 584-593
19. Bruyn R.P.M. The neuropathology of hereditary spastic paraparesis. Clin Neurol Neurosurg 94 (1992) S16-S18
20. Bundey S., and Griffiths M.I. Recurrence risks in families of children with symmetrical spasticity. Dev Med Child Neurol 19 (1977) 179-191
21. Bundey S., Comley L.A., and Blair A. Allan-Herndon syndrome - or X-linked cerebral palsy?. Am J Hum Genet 48 (1991) 1214
22. Burger J., Fonknechten N., Hoeltzenbein M., Neumann L., Bratanoff E., Hazan J., and Reis A. Hereditary spastic paraplegia caused by mutations in the SPG4 gene. Eur J Hum Genet 8 (2000) 771-776
23. Byrne P.C., McMonagle P., Webb S., Fitzgerald B., Parfrey N.A., and Hutchinson M. Age-related cognitive decline in hereditary spastic paraparesis linked to chromosome 2p. Neurology 54 (2000) 1510-1517
24. Cailloux F., Gauthier-Barichard F., Mimault C., Isabelle V., Courtois V., Giraud G., Dastugue B., and Boespflug-Tanguy O. Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease. Eur J Hum Genet 8 (2000) 837-845
25. Cambi F., Tang X.-M., Cordray P., Fain P.R., Keppen L.D., and Barker D.F. Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure hereditary spastic paraplegia. Neurology 46 (1996) 1112-1117
26. Casali C., Valente E.M., Bertini E., Montagna G., Criscuolo C., De Michele G., Villanova M., Damiano M., Pierallini A., Brancati F., Scarano V., Tessa A., Cricchi F., Grieco G.S., Muglia M., Carella M., Martini B., Rossi A., Amabile G.A., Nappi G., Filla A., Dallapiccola B., and Santorelli F.M. Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosum. Neurology 62 (2004) 262-268
27. Casari G., De Fusco M., Ciarmatori S., Zeviani M., Mora M., Fernandez P., De Michele G., Filla A., Cocozza S., Marconi R., Durr A., Fontaine B., and Ballabio A. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93 (1998) 973-983
28. Castellani V., Chedotal A., Schachner M., Faivre-Sarrailh C., and Rougon G. Analysis of the L1-deficient mouse phenotype reveals cross-talk between Sema3A and L1 signaling pathways in axonal guidance. Neuron 27 (2000) 237-249
29. Charvin D., Cifuentes-Diaz C., Fonknechten N., Joshi V., Hazan J., Melki J., and Betuing S. Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus. Hum Mol Genet 12 (2003) 71-78
30. Chinnery P.F., Keers S.M., Holden M.J., Ramesh V., and Dalton A. Infantile hereditary spastic paraparesis due to codominant mutations in the spastin gene. Neurology 63 (2004) 710-712
31. Ciccarelli F.D., Proukakis C., Patel H., Cross H., Azam S., Patton M.A., Bork P., and Crosby A.H. The identification of a conserved domain in both spartin and spastin, mutated in hereditary spastic paraplegia. Genomics 81 (2003) 437-441
32. Claes S., Devriendt K., Van Goethem G., Roelen L., Meireleire J., Raeymaekers P., Cassiman J.J., and Fryns J.P. Novel syndromic form of X-linked complicated spastic paraplegia. Am J Med Genet 94 (2000) 1-4
33. Cohen N.R., Taylor J.S., Scott L.B., Guillery R.W., Soriano P., and Furley A.J. Errors in corticospinal axon guidance in mice lacking the neural cell adhesion molecule L1. Curr Biol 8 (1997) 26-33
34. Coppola M., Pizzigoni A., Banfi S., Bassi M.T., Casari G., and Incerti B. Identification and characterization of YME1L1, a novel paraplegin-related gene. Genomics 66 (2000) 48-54
35. Cross H.E., and McKusick V.A. The Mast syndrome: a recessively inherited form of pre-senile dementia with motor disturbances. Arch Neurol 16 (1967) 1-13
36. Dahme M., Bartsch U., Martini R., Anliker B., Schachner M., and Mantei N. Disruption of the mouse L1 gene leads to malformations of the nervous system. Nat Genet 17 (1997) 346-349
37. Dalpozzo F., Rossetto M.G., Boaretto F., Sartori E., Mostacciuolo M.L., Daga A., Bassi M.T., and Martinuzzi A. Infancy onset hereditary spastic paraplegia associated with a novel atlastin mutation. Neurology 61 (2003) 580-581
38. D'Amico A., Tessa A., Sabino A., Bertini E., Santorelli F.M., and Servidei S. Incomplete penetrance in an SPG3Alinked family with a new mutation in the atlastin gene. Neurology 62 (2004) 2138-2139
39. Daras M., Tuchman A.J., and David S. Familial spinocerebellar ataxia with skin hyperpigmentation. J Neurol Neurosurg Psychiatry 46 (1983) 743-744
40. De Bantel A., McWilliams S., Auysh D., Echol C., Sambuughin N., and Sivakumar K. Novel mutation of the Spastin gene in familial spastic paraplegia. Clin Genet 59 (2001) 364-365
41. Delcroix J.D., Valletta J.S., Wu C., Hunt S.J., Kowal A.S., and Mobley W.C. NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals. Neuron 39 (2003) 69-84
42. Deluca G.C., Ebers G.C., and Esiri M.M. The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol Appl Neurobiol 30 (2004) 576-584
43. Demyanenko G.P., Tsai A.Y., and Maness P.F. Abnormalities in neuronal process extension, hippocampal development, and the ventricular system of L1 knockout mice. J Neurosci 19 (1999) 4907-4920
44. Durr A., Camuzat A., Colin E., Tallaksen C., Hannequin D., Coutinho P., Fontaine B., Rossi A., Gil R., Rousselle C., Ruberg M., Stevanin G., and Brice A. Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. Arch Neurol 61 (2004) 1867-1872
45. Edgar J.M., McLaughlin M., Yool D., Zhang S.C., Fowler J.H., Montague P., Barrie J.A., McCulloch M.C., Duncan I.D., Garbern J., Nave K.A., and Griffiths I.R. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166 (2004) 121-131
46. Elliott J.L. Beginning to understand hereditary spastic paraplegia atlastin. Arch Neurol 61 (2004) 1842-1843
47. Errico A., Ballabio A., and Rugarli E.I. Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Hum Mol Genet 11 (2002) 153-163
48. Errico A., Claudiani P., D'Addio M., and Rugarli E.I. Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon. Hum Mol Genet 13 (2004) 2121-2132
49. Evans K.J., Gomes E.R., Reisenweber S.M., Gundersen G.G., and Lauring B.P. Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing. J Cell Biol 168 (2005) 599-606
50. Falco M., Scuderi C., Musumeci S., Sturnio M., Neri M., Bigoni S., Caniatti L., and Fichera M. Two novel mutations in the spastin gene (SPG4) found by DHPLC mutation analysis. Neuromuscul Disord 14 (2004) 750-753
51. Ferreirinha F., Quattrini A., Pirozzi M., Valsecchi V., Dina G., Broccoli V., Auricchio A., Piemonte F., Tozzi G., Gaeta L., Casari G., Ballabio A., and Rugarli E.I. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J Clin Invest 113 (2004) 231-242
52. Fichera M., Lo Giudice M., Falco M., Sturnio M., Amata S., Calabrese O., Bigoni S., Calzolari E., and Neri M. Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia. Neurology 63 (2004) 1108-1110
53. Filla A., DeMichele G., Marconi R., Bucci L., Carillo C., Castellano A.E., Iorio L., Kniahynicki C., Rossi F., and Campanella G. Prevalence of hereditary ataxias and spastic paraplegias in Molise, a region of Italy. J Neurol 239 (1992) 351-353
54. Fink J.K. Reply to Bohan and Azizi. Arch Neurol 61 (2004) 1471
55. Fonknechten N., Mavel D., Byrne P., Davoine C.S., Cruaud C., Boentsch D., Samson D., Coutinho P., Hutchinson M., McMonagle P., Burgunder J.M., Tartaglione A., Heinzlef O., Feki I., Deufel T., Parfrey N., Brice A., Fontaine B., Prud'homme J.F., Weissenbach J., Durr A., and Hazan J. Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet 9 (2000) 637-644
56. Fontaine B., Davoine C.S., Durr A., Paternotte C., Feki I., Weissenbach J., Hazan J., and Brice A. A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24-q34. Am J Hum Genet 66 (2000) 702-707
57. Fransen E., Lemmon V., Van Camp G., Vits L., Coucke P., and Willems P.J. CRASH syndrome: clinical spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one s. Eur J Hum Genet 3 (1995) 273-284
58. Fransen E., D'Hooge R., Van Camp G., Verhoye M., Sijbers J., Reyniers E., Soriano P., Kamiguchi H., Willemsen R., Koekkoek S.K., De Zeeuw C.I., De Deyn P.P., Van der Linden A., Lemmon V., Kooy R.F., and Willems P.J. L1 knockout mice show dilated ventricles, vermis hypoplasia and impaired exploration patterns. Hum Mol Genet 7 (1998) 999-1099
59. Garbern J.Y., Cambi F., Tang X.M., Sima A.A., Vallat J.M., Bosch E.P., Lewis R., Shy M., Sohi J., Kraft G., Chen K.L., Joshi I., Leonard D.G., Johnson W., Raskind W., Dlouhy S.R., Pratt V., Hodes M.E., Bird T., and Kamholz J. Proteolipid protein is necessary in peripheral as well as central myelin. Neuron 19 (1997) 205-218
60. Garbern J.Y., Yool D.A., Moore G.J., Wilds I.B., Faulk M.W., Klugmann M., Nave K.A., Sistermans E.A., van der Knaap M.S., Bird T.D., Shy M.E., Kamholz J.A., and Griffiths I.R. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelinationand inflammation. Brain 125 (2002) 551-561
61. Goldblatt J., Ballo R., Sachs B., and Moosa A. X-linked spastic paraplegia: evidence for homogeneity with a variable phenotype. Clin Genet 35 (1989) 116-120
62. Goldstein L.S.B. Kinesin molecular motors: transport pathways, receptors and human disease. Proc Natl Acad Sci (USA) 98 (2001) 6999-7003
63. Goldstein L.S.B., and Yang Z. Microtubule-based transport systems in neurons: the role of kinesins and dynamins. Annu Rev Neurosci 23 (2000) 39-71
64. Griffiths I., Kluggmann M., Anderson T., Yool D., Thomson C., Schwabb M.H., Schneider A., Zimmermann F., McCulloch M., Nadon N., and Nave K.A. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280 (1998) 1610-1613
65. Hansen J.J., Durr A., Cournu-Rebeix I., Georgopoulos C., Ang D., Nielsen M.N., Davoine C.S., Brice A., Fontaine B., Gregersen N., and Bross P. Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet 70 (2002) 1328-1332
66. Harding A.E. Hereditary 'pure' spastic paraplegia: a clinical and genetic study of 22 families. J Neurol Neurosurg Psychiatry 44 (1981) 871-883
67. Hazan J., Fonknechten N., Mavel D., Paternotte C., Samson D., Artiguenave F., Davoine C.S., Cruaud C., Durr A., Wincker P., Brottier P., Cattolico L., Barbe V., Burgunder J.M., Prud'homme J.F., Brice A., Fontaine B., Heilig B., and Weissenbach J. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet 23 (1999) 296-303
68. Hedera P., DiMauro S., Bonilla E., Wald J., Eldevik O.P., and Fink J.K. Phenotypic analysis of autosomal dominant hereditary spastic paraplegia linked to chromosome 8q. Neurology 53 (1999) 44-50
69. Hedera P., DiMauro S., Bonilla E., Wald J.J., and Fink J.K. Mitochondrial analysis in autosomal dominant hereditary spastic paraplegia. Neurology 55 (2000) 1591-1592
70. Hedera P., Fenichel G.M., Blair M., and Haines J.L. Novel mutation in the SPG3A gene in an African American family with an early onset of hereditary spastic paraplegia. Arch Neurol 61 (2004) 1600-1603
71. Heinzlef O., Paternotte C., Mahieux F., Prud'homme J.F., Dien J., Madigand M., Pouget J., Weissenbach J., Roullet E., and Hazan J. Mapping of a complicated familial spastic paraplegia to locus SPG4 on chromosome 2p. J Med Genet 35 (1998) 89-93
72. Hentati A., Pericak-Vance M.A., Hung W.Y., Belal S., Laing N., Boustany R.M., Hentati F., Ben Hamida M., and Siddique T. Linkage of 'pure' autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity. Hum Mol Genet 3 (1994) 1263-1267
73. Hentati A., Deng H.X., Zhai H., Chen W., Yang Y., Hung W.Y., Azim A.C., Bohlega S., Tandan R., Warner C., Laing N.G., Cambi F., Mitsumoto H., Roos R.P., Boustany R.M., Ben Hamida M., Hentati F., and Siddique T. Novel mutations in spastin gene and absence of correlation with age at onset of symptoms. Neurology 55 (2000) 1388-1390
74. Higgins J.J., Loveless J.M., Goswami S., Nee L.E., Cozzo C., De Biase A., and Rosen D.R. An atypical intronic deletion widens the spectrum of mutations in hereditary spastic paraplegia. Neurology 56 (2001) 1482-1485
75. Hodgkinson C.A., Bohlega S., Abu-Amero S.N., Cupler E., Kambouris M., Meyer B.F., and Bharucha V.A. A novel form of autosomal recessive pure hereditary spastic paraplegia maps to chromosome 13q14. Neurology 59 (2002) 1905-1909
76. Hughes C.A., Byrne P.C., Webb S., McMonagle P., Patterson V., Hutchinson M., and Parfrey N.A. SPG15, a new locus for autosomal recessive complicated HSP on chromosome 14q. Neurology 56 (2001) 1230-1233
77. Ikenaka K., Kagawa T., and Mikoshiba K. Selective expression of DM-20, an alternatively spliced myelin proteolipid protein gene product, in developing nervous system and in nonglial cells. J Neurochem 58 (1992) 2248-2253
78. Inoue K. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Neurogenetics 6 (2005) 1-16
79. Inoue K., Osaka H., Imaizumi K., Nezu A., Takanashi J., Arii J., Murayama K., Ono J., Kikawa Y., Mito T., Shaffer L.G., and Lupski J.R. Proteolipid protein gene duplications causing Pelizaeus-Merzbacher disease: molecular mechanism and phenotypic manifestations. Ann Neurol 45 (1999) 624-632
80. Inoue K., Tanaka H., Scaglia F., Araki A., Shaffer L.G., and Lupski J.R. Compensating for central nervous system dysmyelination: females with a proteolipid protein gene duplication and sustained clinical improvement. Ann Neurol 50: (2001) 747-754
81. Inoue K., Osaka H., Thurston V.C., Clarke J.T., Yoneyama A., Rosenbarker L., Bird T.D., Hodes M.E., Shaffer L.G., and Lupski J.R. Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females. Am J Hum Genet 71 (2002) 838-853
82. Iwanaga H., Tsujino A., Shirabe S., Eguchi H., Fukushima N., Niikawa N., Yoshiura K.I., and Eguchi K. Large deletion involving the 5′-UTR in the spastin gene caused mild phenotype of autosomal dominant hereditary spastic paraplegia. Am J Med Genet A 133A (2005) 13-17
83. Johnson A.W., and McKusick V.A. A sex-linked recessive form of spastic paraplegia. Am J Hum Genet 14 (1962) 83-94
84. Joosten E.A., and Gribnau A.A. Immunological localization of cell adhesion molecule L1 in developing rat pyramidal tract. Neurosci Lett 100 (1998) 94-98
85. Jouet M., Rosenthal A., Armstrong G., MacFarlane J., Stevenson R., Paterson J., Metzenberg A., Ionasecu V., Temple K., and Kenwrick S. X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene. Nat Genet 7 (1994) 402-407
86. Kenwrick S., Ionasescu V., Ionasescu G., Searby C., King A., Dubowitz M., and Davies K.E. Linkage studies of X-linked recessive spastic paraplegia using DNA probes. Hum Genet 73 (1986) 264-266
87. Keppen L.D., Leppert M.F., O'Connel P., Nakamura Y., Stauffer D., Lathrop M., Lalouel J.-M., and White R. Etiological heterogeneity in X-linked spastic paraplegia. Am J Hum Genet 41 (1987) 933-943
88. Ki C.S., Lee W.Y., Han do H., Sung D.H., Lee K.B., Lee K.A., Cho S.S., Cho S., Hwang H., Sohn K.M., Choi Y.J., and Kim J.W. A novel missense mutation (I344K) in the SPG4gene in a Korean family with autosomal-dominant hereditary spastic paraplegia. J Hum Genet 47 (2002) 473-477
89. Kluggmann M.M.H.S., Puhlhofer A., Schneider A., Zimmermann F., Griffiths I.R., and Nave K.-A. Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18 (1997) 59-70
90. Kramer W. Hereditary spinal spastic paraplegia (Strumpell-Lorrain's disease). Neuropathol Appl Neurobiol 8 (1977) 488-489
91. Langer T., and Neupert W. Regulated protein degradation in mitochondria. Experimentia 52 (1996) 1069-1076
92. Leone M., Bottachi E., D'Alessandro G., and Kustermann S. Hereditary ataxias and paraplegias in Valle d'Aosta, Italy: a study of prevalence and disability. Acta Neurol Scand 91 (1995) 183-187
93. Lindsey J.C., Lusher M.E., McDermott C.J., White K.D., Reid E., Rubinsztein D.C., Bashir R., Hazan J., Shaw P.J., and Bushby K.M. Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis. J Med Genet 37 (2000) 759-765
94. Lison M., Kornbrut B., Feinstein A., Hiss Y., Boichis H., and Goodman R.M. Progressive spastic paraparesis, vitiligo, premature graying, and distinct facial appearance: a new genetic syndrome in 3 sibs. Am J Med Genet 9 (1981) 351-357
95. Lo Nigro C., Cusano R., Scaranari M., Cinti R., Forabosco P., Morra V.B., De Michele G., Santoro L., Davies S., Hurst J., Devoto M., Ravazzolo R., and Seri M. A refined physical and transcriptional map of the SPG9 locus on 10q23.3-q24.2. Eur J Hum Genet 8 (2000) 777-782
96. Manfredi G., and Beal F. The role of mitochondria in the pathogenesis of neurodegenerative disorders. Brain Pathol 10 (2000) 462-472
97. McDermott C.J., Dayaratne R.K., Tomkins J., Lusher M.E., Lindsey J.C., Johnson M.A., Casari G., Turnbull D.M., Bushby K., and Shaw P.J. Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England. Neurology 56 (2001) 467-471
98. McDermott C.J., Grierson A.J., Wood J.D., Bingley M., Wharton S.B., Bushby K.M., and Shaw P.J. Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation. Ann Neurol 54 (2003) 748-759
99. McDermott C.J., Taylor R.W., Hayes C., Johnson M., Bushby K.M., Turnbull D.M., and Shaw P.J. Investigation of mitochondrial function in hereditary spastic paraparesis. Neuroreport 14 (2003) 485-488
100. McMonagle P., Byrne P.C., Fitzgerald B., Webb S., Parfrey N.A., and Hutchinson M. Phenotype of AD-HSP due to mutations in the SPAST gene: comparison with AD-HSP without mutations. Neurology 55 (2000) 1794-1800
101. McMonagle P., Byrne P., and Hutchinson M. Further evidence of dementia in SPG4-linked autosomal dominant hereditary spastic paraplegia. Neurology 62 (2004) 407-410
102. Mead S.H., Proukakis C., Wood N., Crosby A.H., Plant G.T., and Warner T.T. A large family with hereditary spastic paraparesis due to a frame shift mutation of the spastin (SPG4) gene: association with multiple sclerosis intwo affected siblings and epilepsy in other affected family members. J Neurol Neurosurg Psychiatry 71 (2001) 788-791
103. Meijer I.A., Hand C.K., Cossette P., Figlewicz D.A., and Rouleau G.A. Spectrum of SPG4 mutations in a large collection of North American families with hereditary spastic paraplegia. Arch Neurol 59 (2002) 281-286
104. Meijer I.A., Cossette P., Roussel J., Benard M., Toupin S., and Rouleau G.A. A novel locus for pure recessive hereditary spastic paraplegia maps to 10q22.1-10q24.1. Ann Neurol 56 (2004) 579-582
105. Michaelis R.C., Du Y.Z., and Schwartz C.E. The site of a missense mutation in the extracellular Ig or FN domains of L1CAM influences infant mortality and the severity of X linkedhydrocephalus. J Med Genet 35 (1998) 901-904
106. Mimault C., Giraud G., Courtois V., Cailloux F., Boire J.Y., Dastugue B., and Boespflug-Tanguy O. Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher disease: duplications, the major cause of the disease, originatemore frequently in male germ cells, but point mutations do not. The Clinical European Network on Brain Dysmyelinating Disease. Am J Hum Genet 65 (1999) 360-369
107. Molon A., Montagna P., Angelini C., and Pegoraro E. Novel spastin mutations and their expression analysis in two Italian families. Eur J Hum Genet 11 (2003) 710-713
108. Morita M., Ho M., Hosler B.A., McKenna-Yasek D., and Brown Jr. R.H. A novel mutation in the spastin gene in a family with spastic paraplegia. Neurosci Lett 325 (2002) 57-61
109. Muglia M., Magariello A., Nicoletti G., Patitucci A., Gabriele A.L., Conforti F.L., Mazzei R., Caracciolo M., Ardito B., Lastilla M., Tedeschi G., and Quattrone A. Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia. Ann Neurol 51 (2002) 794-795
110. Murillo F., Kobayashi H., Pegoraro E., Galluzzi G., Creel G., Mariana C., Farina E., Ricci Em Alfonso G., Pauli R.M., and Hoffman E.P. Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15. Neurology 53 (1999) 50-56
111. Namekawa M., Takiyama Y., Sakoe K., Nagaki H., Shimazaki H., Yoshimura M., Ikeguchi K., Nakano I., and Nishizawa M. A large Japanese SPG4 family with a novel insertion mutation of the SPG4 gene: a clinical and genetic study. J Neurol Sci 185 (2001) 63-68
112. Namekawa M., Takiyama Y., Sakoe K., Shimazaki H., Amaike M., Niijima K., Nakano I., and Nishizawa M. A Japanese SPG4 family with a novel missense mutation of the SPG4 gene: intrafamilial variability in age at onset and clinical severity. Acta Neurol Scand 106 (2002) 387-391
113. Nicholas A.P., O'Hearn E., Holmes S.E., Chen D.T., and Margolis R.L. Clinical signs and symptoms in a large hereditary spastic paraparesis pedigree with a novel spastin mutation. Mov Disord 19 (2004) 641-648
114. Nielsen J.E., Johnsen B., Koefoed P., Scheuer K.H., Gronbech-Jensen M., Law I., Krabbe K., Norremolle A., Eiberg H., Sondergard H., Dam M., Rehfeld J.F., Krarup C., Paulson O.B., Hasholt L., and Sorensen S.A. Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation. Eur J Neurol 11 (2004) 817-824
115. Nielsen J.E., Koefoed P., Kjaergaard S., Jensen L.N., Norremolle A., and Hasholt L. Prenatal diagnosis of autosomal dominant hereditary spastic paraplegia (SPG4) using direct mutation detection. Prenat Diagn 24 (2004) 363-366
116. Orlacchio A., Kawarai T., Rogaeva E., Song Y.Q., Paterson A.D., Bernardi G., and St George-Hyslop P.H. Clinical and genetic study of a large Italian family linked to SPG12 locus. Neurology 59 (2002) 1395-1401
117. Orlacchio A., Gaudiello F., Totaro A., Floris R., St George-Hyslop P.H., Bernardi G., and Kawarai T. A new SPG4 mutation in a variant form of spastic paraplegia with congenital arachnoid cysts. Neurology 62 (2004) 1875-1878
118. Orlacchio A., Kawarai T., Totaro A., Errico A., St George-Hyslop P.H., Rugarli E.I., and Bernardi G. Hereditary spastic paraplegia: clinical genetic study of 15 families. Arch Neurol 61 (2004) 849-855
119. Patel H., Hart P.E., Warner T., Allen I., Phillimore H.E., Silver J.R., Wood N.W., Jeffery S., Patton M.A., and Crosby A.H. Silver syndrome is not linked to any of the previously established autosomal dominant hereditary spastic paraplegia loci. Am J Med Genet 102 (2001) 68-72
120. Patel H., Cross H., Proukakis C., Hershberger R., Bork P., Ciccarelli F.D., Patton M.A., McKusick V.A., and Crosby A.H. SPG20 is mutated in Troyer syndrome, a hereditary spastic paraplegia. Nat Genet 31 (2002) 37-38
121. Patrono C., Casali C., Tessa A., Cricchi F., Fortini D., Carrozzo R., Siciliano G., Bertini E., and Santorelli F.M. Missense and splice site mutations in SPG4 suggest loss-of-function in dominant spastic paraplegia. J Neurol 249 (2002) 200-205
122. Paul M.-F., and Tzagoloff A. Mutations in RCA1 and AFG3 inhibit F-ATPase assembly in Saccharomyces cerevisiae. FEBS Lett 373 (1995) 66-70
123. Peyron F., Timsit S., Thomas J.L., Kagawa T., Ikenaka K., and Zalc B. In situ expression of PLP/DM-20, MBP, and CNP during embryonic and postnatal development of the jimpy mutant and of transgenic mice overexpressing PLP. J Neurosci Res 50 (1997) 190-201
124. Piemonte F., Casali C., Carrozzo R., Schagger H., Patrono C., Tessa A., Tozzi G., Cricchi F., Di Capua M., Siciliano G., Amabile G.A., Morocutti C., Bertini E., and Santorelli F.M. Respiratory chain defects in hereditary spastic paraplegias. Neuromuscul Disord 11 (2001) 565-569
125. (Pt 2). Polo J.M., Calleja J., Combarros O., and Berciano J. Hereditary ataxias and paraplegias in Cantabria, Spain. An epidemiological and clinical study. Brain 114 (1991.) 855-866
126. Proukakis C., Hart P.E., Cornish A., Warner T.T., and Crosby A.H. Three novel spastin (SPG4) mutations in families with autosomal dominant hereditary spastic paraplegia. J Neurol Sci 201 (2002) 65-69
127. Proukakis C., Auer-Grumbach M., Wagner K., Wilkinson P.A., Reid E., Patton M.A., Warner T.T., and Crosby A.H. Screening of patients with hereditary spastic paraplegia reveals seven novel mutations in the SPG4 (Spastin) gene. Hum Mutat 21 (2003) 170
128. Proukakis C., Cross H., Patel H., Patton M.A., Valentine A., and Crosby A.H. Troyer syndrome revisited. A clinical and radiological study of a complicated hereditary spastic paraplegia. J Neurol 251 (2004) 1105-1110
129. Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L., Tokito M., Mann E., Floeter M.K., Bidus K., Drayna D., Oh S.J., Brown Jr. R.H., Ludlow C.L., and Fischbeck K.H. Mutant dynactin in motor neuron disease. Nat Genet 33 (2003) 455-456
130. Qin W., Zhang T., Han J., Tang L., Li X., Feng G., Liu W., and He L. A novel insertion mutation in spastin gene is the cause of spastic paraplegia in a Chinese family. J Neurol Sci 210 (2003) 35-39
131. Rainier S., Chai J.H., Tokarz D., Nicholls R.D., and Fink J.K. NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). Am J Hum Genet 73 (2003) 967-971
132. Raskind W.H., Williams C.A., Hudson L.D., and Bird T.D. Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. Am J Hum Genet 49 (1991) 1355-1360
133. Epub. Reed J.A., Wilkinson P.A., Patel H., Simpson M.A., Chatonnet A., Robay D., Patton M.A., Crosby A.H., and Warner T.T. A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegia. Neurogenetics (2005)
134. Reid E., Dearlove A.M., Whiteford M.L., Rhodes M., and Rubinsztein D.C. Autosomal dominant spastic paraplegia: refined SPG8 locus and additional genetic heterogeneity. Neurology 53 (1999) 1844-1849
135. Reid E., Dearlove A.M., Osborn O., Rogers M.T., and Rubinsztein D.C. A locus for autosomal dominant 'pure' hereditary spastic paraplegia maps to chromosome 19q13. Am J Hum Genet 66 (2000) 728-732
136. Reid E., Kloos M., Ashley-Koch A., Hughes L., Bevan S., Svenson I.K., Graham F.L., Gaskell P.C., Dearlove A., Pericak-Vance M.A., Rubinsztein D.C., and Marchuk D.A. A kinesin heavy chain (KIF5A). mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 71 (2002) 1189-1194
137. Reid E., Connell J., Edwards T.L., Duley S., Brown S.E., and Sanderson C.M. The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B. Hum Mol Genet 14 (2005) 19-38
138. Renier W.O., Gabreels F.J., Hustinx T.W., Jaspar H.H., Geelen J.A., Van Haelst U.J., and Ter Haar B.G. Connatal Pelizaeus-Merzbacher disease with congenital stridor in two maternal cousins. Acta Neuropath 54 (1981) 11-17
139. Rep M., and Grivell L.A. The role of protein degradation in mitochondrial function and biogenesis. Curr Genet 30 (1996) 367-380
140. Rocco P., Vainzof M., Froehner S.C., Peters M.F., Marie S.K., Passos-Bueno M.R., and Zatz M. Brazilian family with pure autosomal dominant spastic paraplegia maps to 8q: analysis of muscle beta 1 syntrophin. Am J Med Genet 92 (2000) 122-127
141. Sack G.H., Huether C.A., and Garg N. Familial spastic paraplegia: clinical and pathological studies in a large kindred. Johns Hopkins Med J 143 (1978) 117-121
142. Saugier-Veber P., Munnich A., Bonneau D., Rozet J.-M., Le Merrer M., Gil R., and Boespflug-Tanguy O. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet 6 (1994) 257-261
143. Sauter S., Miterski B., Klimpe S., Bonsch D., Schols L., Visbeck A., Papke T., Hopf H.C., Engel W., Deufel T., Epplen J.T., and Neesen J. Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia. Hum Mutat 20 (2002) 127-132
144. Sauter S.M., Engel W., Neumann L.M., Kunze J., and Neesen J. Novel mutations in the Atlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late onset forms ofHSP linked to the SPG3A locus. Hum Mutat 23 (2004) 98
145. Schwarz G.A. Hereditary (familial) spastic paraplegia. AMA Arch Neurol Psychiatry 68 (1952) 655-662
146. Schwarz G.A., and Liu C.N. Hereditary (familial) spastic paraplegia; further clinical and pathologic observations. AMA Arch Neurol Psychiatry 75 (1956) 144-162
147. Seri M., Cusano R., Forabosco P., Cinti R., Caroli F., Picco P., Bini R., Morra V.B., De Michele G., Lerone M., Silengo M., Pela I., Borrone C., Romeo G., and Devoto M. Genetic mapping to 10q23.3-q24.2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spasticparaparesis with amyotrophy. Am J Hum Genet 64 (1999) 586-593
148. Sherwood N.T., Sun Q., Xue M., Zhang B., and Zinn K. Drosophila spastin regulates synaptic microtubule networks and is required for normal motor function. PLoS Biol 2 (2004) e429
149. Shibasaki Y., Tanaka H., Iwabuchi K., Kawasaki S., Kondo H., Uekawa K., Ueda M., Kamiya T., Katayama Y., Nakamura A., Takashima H., Nakagawa M., Masuda M., Utsumi H., Nakamuro T., Tada K., Kurohara K., Inoue K., Koike F., Sakai T., Tsuji S., and Kobayashi H. Linkage of autosomal recessive hereditary spastic paraplegia with mental impairment and thin corpus callosum to chromosome 15A13-15. Ann Neurol 48 (2000) 108-112
150. Silva M.C., Coutinho P., Pinheiro C.D., Neves J.M., and Serrano P. Hereditary ataxias and spastic paraplegias: methological aspects of a prevalence study in Portugal. J Clin Epidemiol 50 (1997) 1377-1384
151. Silver J.R. Familial spastic paraplegia with amyotrophy of the hands. Ann Hum Genet 30 (1966) 69-75
152. Simpson M.A., Cross H., Proukakis C., Pryde A., Hershberger R., Chatonnet A., Patton M.A., and Crosby A.H. Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am J Hum Genet 73 (2003) 1147-1156
153. Sistermans E.A., de Wijs I.J., de Coo R.F., Smit L.M., Menko F.H., and van Oost B.A. A (G-to-A) mutation in the initiation codon of the proteolipid protein gene causing a relatively mild form of Pelizaeus-Merzbacher disease in a Dutch family. Hum Genet 97 (1996) 337-339
154. Sistermans E.A., de Coo R.F., De Wijs I.J., and Van Oost B.A. duplication of the proteolipid protein gene is the major cause of Pelizaeus-Merzbacher disease. Neurology 50 (1998) 1749-1754
155. Sivakumar K., Sambuughin N., Selenge B., Nagle J.W., Baasanjav D., Hudson L.D., and Goldfarb L.G. Novel exon 3B proteolipid protein gene mutation causing lateonset spastic paraplegia type 2 with variable penetrance in female family members. Ann Neurol 45 (1999) 680-683
156. Slavotinek A.M., Pike M., Mills K., and Hurst J.A. Cataracts, motor system disorder, short stature, learning difficulties, and skeletal abnormalities: a new syndrome?. Am J Med Genet 62 (1996) 42-47
157. Song H., and Endow S.A. Decoupling of nucleotide- and microtubule-binding sites in a kinesin mutant. Nature 396 (1998) 587-590
158. Starling A., Rocco P., Cambi F., Hobson G.M., Passos Bueno M.R., and Zatz M. Further evidence for a fourth gene causing X-linked pure spastic paraplegia. Am J Med Genet 111 (2002) 152-156
159. Starling A., Rocco P., Passos-Bueno M.R., Hazan J., Marie S.K., and Zatz M. Autosomal dominant (AD) pure spastic paraplegia (HSP) linked to locus SPG4 affects almost exclusively males in a large pedigree. J Med Genet 39 (2002) e77
160. Steinmuller R., Lantigua-Cruz A., Garcia-Garcia R., Kostrzewa M., Steinberger D., and Muller U. Evidence of a third locus in X-linked recessive paraplegia. Hum Genet 100 (1997) 287-289
161. Stevenson R.E., Goodman H.O., Schwartz C.E., Simensen R.J., McLean Jr. W.T., and Herndon C.N. Allan-Herndon syndrome. I. Clinical studies. Am J Hum Genet 47 (1990) 446-453
162. Stewart R.M., Tunell G., and Ehle A. Familial spastic paraplegia, peroneal neuropathy, and crural hypopigmentation: a new neurocutaneous syndrome. Neurology 31 (1981) 754-757
163. Svenson I.K., Ashley-Koch A.E., Gaskell P.C., Riney T.J., Cumming W.J., Kingston H.M., Hogan E.L., Boustany R.M., Vance J.M., Nance M.A., Pericak-Vance M.A., and Marchuk D.A. Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. Am J Hum Genet 68 (2001) 1077-1085
164. Svenson I.K., Ashley-Koch A.E., Pericak-Vance M.A., and Marchuk D.A. A second leaky splice-site mutation in the spastin gene. Am J Hum Genet 69 (2001) 1407-1409
165. Svenson I.K., Kloos M.T., Gaskell P.C., Nance M.A., Garbern J.Y., Hisanaga S., Pericak-Vance M.A., Ashley-Koch A.E., and Marchuk D.A. Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations. Neurogenetics 5 (2004) 157-164.
166. Tamagaki A., Shima M., Tomita R., Okumura M., Shibata M., Morichika S., Kurahashi H., Giddings J.C., Yoshioka A., and Yokobayashi Y. Segregation of a pure form of spastic paraplegia and NOR insertion into Xq11.2. Am J Med Genet 94 (2000) 5-8
167. Tang B., Zhao G., Xia K., Pan Q., Luo W., Shen L., Long Z., Dai H., Zi X., and Jiang H. Three novel mutations of the spastin gene in Chinese patients with hereditary spastic paraplegia. Arch Neurol 61 (2004) 49-55
168. Tauer R., Mannhaupt G., Schnall R., Pajic A., Langer T., and Feldmann H. Yta10p, a member of a novel ATPase family in yeast, is essential for mitochondrial function. FEBS Lett 353 (1994) 197-200
169. Tessa A., Casali C., Damiano M., Bruno C., Fortini D., Patrono C., Cricchi F., Valoppi M., Nappi G., Amabile G.A., Bertini E., and Santorelli F.M. SPG3A: An additional family carrying a new atlastin mutation. Neurology 59 (2002) 2002-2005
170. Timsit S., Martinez S., Allinquant B., Peyron F., Puelles L., and Zalc B. Oligodendrocytes originate in a restricted zone of the embryonic ventral neural tube defined by DM-20 mRNA expression. J Neurosci 15 (1995) 1012-1024
171. Trotta N., Orso G., Rossetto M.G., Daga A., and Broadie K. The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function. Curr Biol 14 (2004) 1135-1147
172. Tzagoloff A., Yue J., Jang J., and Paul M.-F. A new member of a family of ATPases is essential for assembly of mitochondrial respiratory chain and ATP synthetase complexes in Saccharomycescerevisiae. Mol Cell Biol 13 (1994) 5418-5426
173. Valente E.M., Brancati F., Caputo V., Bertini E., Patrono C., Costanti D., and Dallapiccola B. Novel locus for autosomal dominant pure hereditary spastic paraplegia (SPG19) maps to chromosome 9q33-q34. Ann Neurol 51 (2002) 681-685
174. Vazza G., Zortea M., Boaretto F., Micaglio G.F., Sartori V., and Mostacciuolo M.L. A new locus for autosomal recessive spastic paraplegia associated with mental retardation and distal motor neuropathy, SPG14, maps to chromosome3q27-q28. Am J Hum Genet 67 (2000) 504-509
175. Warner T.T., Patel H., Proukakis C., Reed J.A., McKie L., Wills A., Patton M.A., and Crosby A.H. A clinical, genetic and candidate gene study of Silver syndrome, a complicated form of hereditary spastic paraplegia. J Neurol 251 (2004) 1068-1074
176. (Pt 4). Webb S., Coleman D., Byrne P., Parfrey N., Burke T., Hutchinson J., and Hutchinson M. Autosomal dominant hereditary spastic paraparesis with cognitive loss linked to chromosome 2p. Brain 121 (1998) 601-609
177. Wharton S.B., McDermott C.J., Grierson A.J., Wood J.D., Gelsthorpe C., Ince P.G., and Shaw P.J. The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene. J Neuropathol Exp Neurol 62 (2003) 1166-1177
178. White K.D., Ince P.G., Lusher M., Lindsey J., Cookson M., Bashir R., Shaw P.J., and Bushby K.M. Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutation. Neurology 55 (2000) 89-94
179. Wilkinson P.A., Crosby A.H., Turner C., Patel H., Wood N.W., Schapira A.H., and Warner T.T. A clinical and genetic study of SPG5A linked autosomal recessive hereditary spastic paraplegia. Neurology 61 (2003) 235-238
180. Wilkinson P.A., Crosby A.H., Turner C., Bradley L.J., Ginsberg L., Wood N.W., Schapira A.H., and Warner T.T. A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia. Brain 127 (2004) 973-980
181. Wilkinson P.A., Simpson M.A., Bastaki L., Patel H., Reed J.A., Kalidas K., Samilchuk E., Khan R., Warner T.T., and Crosby A.H. A new locus for autosomal recessive complicated hereditary spastic paraplegia (SPG26) maps to chromosome 12p11.1-12q14. J Med Genet 42 (2005) 80-82
182. Windpassinger C., Wagner K., Petek E., Fischer R., and Auer-Grumbach M. Refinement of the Silver syndrome locus on chromosome 11q12-q14 in four families and exclusion of eight candidate genes. Hum Genet 114 (2003) 99-109
183. Windpassinger C., Auer-Grumbach M., Irobi J., Patel H., Petek E., Horl G., Malli R., Reed J.A., Dierick I., Verpoorten N., Warner T.T., Proukakis C., Van den Bergh P., Verellen C., Van Maldergem L., Merlini L., De Jonghe P., Timmerman V., Crosby A.H., and Wagner K. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet 36 (2004) 271-276
184. Winner B., Uyanik G., Gross C., Lange M., Schulte-Mattler W., Schuierer G., Marienhagen J., Hehr U., and Winkler J. Clinical progression and genetic analysis in hereditary spastic paraplegia with thin corpus callosum in spastic gait gene 11 (SPG11). Arch Neurol 61 (2004) 117-121
185. Wong A., Cavelier L., Collins-Schramm H.E., Seldin M.F., McGrogan M., Savontaus M.L., and Cortopassi G.A. Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells. Hum Mol Genet 11 (2002) 431-438
186. Woodward K., Kendall E., Vetrie D., and Malcolm S. Pelizaeus-Merzbacher disease: identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH. Am J Hum Genet 63 (1998) 207-217
187. Xia C., Rahman A., Yang Z., and Goldstein L.S. Chromosomal localization reveals three kinesin heavy chain genes in mouse. Genomics 52 (1998) 209-213
188. Yabe I., Sasaki H., Tashiro K., Matsuura T., Takegami T., and Satoh T. Spastin gene mutation in Japanese with hereditary spastic paraplegia. J Med Genet 39 (2002) e46
189. Yu W.P., Collarini E.J., Pringle N.P., and Richardson W.D. Embryonic expression of myelin genes: evidence for a focal source of oligodendrocyte precursors in the ventricular zone of the neural tube. Neuron 12 (1994) 1353-1362
190. Yun M., Zhang X., Park C.G., Park H.W., and Endow S.A. A structural pathway for activation of the kinesin motor ATPase. EMBO J 20 (2001) 2611-2618
191. Zeitlmann L., Sirim P., Kremmer E., and Kolanus W. Cloning of ACP33 as a novel intracellular ligand of CD4. J Biol Chem 276 (2001) 9123-9132
192. Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., Yang H.W., Terada S., Nakata T., Takei Y., Saito M., Tsuji S., Hayashi Y., and Hirokawa N. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1B beta. Cell 105 (2001) 587-597
193. Zhao X., Alvarado D., Rainier S., Lemons R., Hedera P., Weber C.H., Tukel T., Apak M., Heiman-Patterson T., Ming L., Bui M., and Fink J.K. Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet 29 (2001) 326-331
194. Zhu P.P., Patterson A., Lavoie B., Stadler J., Shoeb M., Patel R., and Blackstone C. Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin. J Biol Chem 278 (2003) 49063-49071
195. Zortea M., Vettori A., Trevisan C.P., Bellini S., Vazza G., Armani M., Simonati A., and Mostacciuolo M.L. Genetic mapping of a susceptibility locus for disc herniation and spastic paraplegia on 6q23.3-q24.1. J Med Genet 39 (2002) 387-390